منابع مشابه
Stent-versus-stent equivalency trials : are some stents more equal than others?
New endovascular stent designs are displacing triedand-true devices for use in an ever-broader array of lesions. Yet disagreement remains as to which device is most advantageous and whether design determines outcome. Preclinical research says that this should be the case, but clinical trials have failed to validate design dependence. Is this yet another demonstration of the dichotomy between pr...
متن کاملOverview of Intracoronary Brachytherapy for in-Stent Restenosis of a Drug-Eluting Stent
Percutaneous coronary intervention with stenting is considered recently as the most common procedure for the treatment of symptomatic coronary. The article reviewed 41 studies published during 1997-2019 on intracoronary brachytherapy for in-stent restenosis of a drug-eluting stent. Intracoronary radiation therapy was finally confirmed in the setting of in-stent restenosis using as adjunctive th...
متن کاملPooled analysis of two randomized trials comparing titanium-nitride-oxide-coated stent versus drug-eluting stent in STEMI.
INTRODUCTION AND OBJECTIVES We performed a pooled analysis based on patient-level data from the TITAX-AMI and BASE-ACS trials to evaluate the outcome of titanium-nitride-oxide-coated bioactive stents vs drug-eluting stents in patients with ST-segment elevation myocardial infarction at 2-year follow-up. METHODS The TITAX-AMI trial compared bioactive stents with paclitaxel-eluting stents in 425...
متن کاملRisk of late-acquired incomplete stent apposition after drug-eluting stent versus bare-metal stent. A meta-analysis from 12 randomized trials.
BACKGROUND Incomplete stent apposition (ISA) is an unusual finding of intravascular ultrasound (IVUS) that may occur both after drug-eluting stent (DES) or bare-metal stent (BMS) implantation and could be associated with late stent thrombosis. Controversy still remains about whether the risk of late-acquired ISA is increased after DES implantation. This meta-analysis aimed to clarify whether DE...
متن کاملStent trials in acute myocardial infarction.
myocardial infarction has been demonstrated to reduce in-hospital major adverse events. PTCA has been shown to result in lower rates of mortality, recurrent myocardial infarction and stroke than t h r o m b o l y s i s . – 3 Furthermore, this result was also demonstrated in the GUSTO IIB trial, the largest randomized comparison between PTCA and thrombolysis. However, recurrent ischemia, early r...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Circulation
سال: 1999
ISSN: 0009-7322,1524-4539
DOI: 10.1161/01.cir.100.9.896